Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines

C Anish, M Beurret, J Poolman - npj Vaccines, 2021 - nature.com
… proteins and medium-sized oligosaccharides end-linked to … subsequent conjugation efficiency
in vaccine manufacturing. … trial in the United States determined 94.4% efficacy of HbOC

Neuroinfectious Disease Emergencies

CRS McEntire, P Anand… - Neurologic …, 2021 - neurologic.theclinics.com
Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC)
vaccine in a United States population of 61,080 children. The …

[HTML][HTML] Meningitis post-cochlear implant and role of vaccination

GA Alanazi, AS Alrashidi, KS Alqarni… - Saudi Medical …, 2022 - ncbi.nlm.nih.gov
Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC)
vaccine in a United States population of 61,080 children. The …

[HTML][HTML] Immunobiology of carbohydrates: implications for novel vaccine and adjuvant design against infectious diseases

G Stefanetti, F Borriello, B Richichi, I Zanoni… - Frontiers in Cellular and …, 2022 - frontiersin.org
… Of note, D-mannose monosaccharides or oligosaccharides conjugated with antigens …
Haemophilus Influenzae Type B (HbOC) Vaccine in a United States Population of 61,080 Children

[PDF][PDF] Haemophilus influenzae

M Lefebvre, G Melica - Revue des Maladies Respiratoires Actualités, 2020 - Elsevier
Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC)
vaccine in a United States population of 61,080 children. The …

[HTML][HTML] Immunizations in hematopoietic cell transplant candidates and recipients

PL Hibberd - UpToDate., 2022 - medilib.ir
Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC)
vaccine in a United States population of 61,080 children. The …

Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques

…, NE Lora, DL Barber, MJ Aman, H Karauzum - Frontiers in …, 2021 - frontiersin.org
Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC)
vaccine in a United States population of 61,080 children. The …

Safety and Immunogenicity of a 4-Component Toxoid-Based

A Venkatasubramaniam, G Liao, E Cho… - Fighting an Elusive …, 2022 - books.google.com
Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC)
vaccine in a United States population of 61080 children. The …

Modular platforms for the assembly of self-adjuvanting lipopeptide-based vaccines for use in an out-bred population

W Zeng, KJ Horrocks, ACL Tan, CY Wong, BY Chua… - Vaccine, 2020 - Elsevier
… of vaccine constructs including a lipopeptide-protein conjugate … The efficacy of these
vaccines in an outbred population … morbidity and mortality in children in the developed world. …

[HTML][HTML] Пневмонии у пациентов с множественной миеломой: результаты проспективного исследования клинического эффекта пневмококковой вакцинации

ИО Стома, ИА Искров, ИЮ Лендина… - Вестник гематологии, 2020 - cyberleninka.ru
Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC)
vaccine in a United States population of 61,080 children. The …